Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
A Unique Structure for Tackling Psoriatic Disease
GRAPPA brings together a group of highly motivated physicians to address these complex disorders
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Science from our Sisters
Recommended reading from A&R and AC&R
- « Previous Page
- 1
- …
- 15
- 16
- 17